Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Developing and Validating Brain Tumor Organoid Models To Evaluate Novel Therapeutics in Vitro

April 2025 Bioprinting, Bioprocessing, Blood, Cancer, Cell Therapy, Clinical, Tissue Engineering

CYR61 Delivery Promotes Angiogenesis During Bone Fracture Repair

April 2025 Blood, Cardiovascular, Cell Therapy, Orthopedic

Cold Quad-Modal Nanocomplex for Precise and Quantitative in Vivo Stem Cell Tracking

April 2025 Cell Therapy

Impacts of Inorganic Arsenic Exposure on Genetic Stability of Human Mesenchymal Stromal Cells

April 2025 Bioprinting, Bioprocessing, Cell Therapy, Drug Screening, Tissue Engineering

3D-printed beta-TCP Scaffold as a Bone-Mimicking Environment for An Engineered Model of Osteosarcoma: in Vitro Properties and Transcriptomic Insights

April 2025 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Clinical, Drug Screening, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Extracellular Particles Derived From Mesenchymal Stromal Cells Reduce Pseudomonas Aeruginosa Lung Infection and Inflammation in Mice

March 2025 Bioprinting, Cell Therapy, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Tissue Engineering

Supercritical CO(2) With Enzymatic Posttreatment Enhances Mechanical and Biological Properties of Cancellous Bovine Bone Block Grafts

March 2025 Bioprinting, Cell Therapy, Clinical, Orthopedic, Tissue Engineering

Exosomes in Precision Oncology and Beyond: From Bench To Bedside in Diagnostics and Therapeutics

March 2025 Bioprocessing, Cancer, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Gene Editing, Immunomodulation

High Throughput Morphological Screening Identifies Chemically Defined Media for Mesenchymal Stromal Cells That Enhances Proliferation and Supports Maintenance of Immunomodulatory Function

March 2025 Bioprocessing, Cell Therapy, Clinical, Drug Screening, Immunomodulation

Overexpression of Fibroblast Activation Protein (FAP) in The Stroma of Proliferative Inflammatory Atrophy (PIA) and Primary Adenocarcinoma of The Prostate

March 2025 Bioprinting, Cancer, Cell Therapy, Clinical, Immunomodulation, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 27 28 29 30 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email